Some central pharmacological effects of the calcium channel antagonist flunarizine
- PMID: 2031709
- DOI: 10.1007/BF01253388
Some central pharmacological effects of the calcium channel antagonist flunarizine
Abstract
Our earlier studies showed that dihydropyridine calcium channel antagonists have some central pharmacological effects. Flunarizine is considered to be a calcium channel antagonist; therefore this study was aimed at investigating the effect of flunarizine (given in single doses of 5, 10 and 20 mg/kg p.o.) in behavioural models in which calcium channel antagonists of the dihydropyridine type were previously studied. Flunarizine inhibited the apomorphine-induced stereotypy and yawning behaviour in rats. It decreased the hypothermia induced by a low dose of apomorphine in mice, but not that one induced by high dose of it. The quinpirole-induced hypothermia was also reduced. In the tests used for evaluation of the effect on the serotonergic system, flunarizine decreased the 5-HTP-induced head twitches and partly antagonized the fenfluramine- and quipazine-induced hyperthermias (at a high ambient temperature). In the forced swimming test flunarizine was inactive in mice and rats. The obtained results indicate that flunarizine exerts central antagonistic effects on the dopaminergic and serotonergic systems and has no antidepressant activity. Flunarizine differs from calcium channel antagonists of the dihydropyridine type, which have no dopamine-antagonistic activity and show anti-depressant-like properties.
Similar articles
-
Pharmacological involvement of the calcium channel blocker flunarizine in dopamine transmission at the striatum.Parkinsonism Relat Disord. 2001 Sep;8(1):33-40. doi: 10.1016/s1353-8020(01)00006-2. Parkinsonism Relat Disord. 2001. PMID: 11472878
-
Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.Pol J Pharmacol Pharm. 1985 Mar-Apr;37(2):179-96. Pol J Pharmacol Pharm. 1985. PMID: 4048012
-
A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.Br J Pharmacol. 1985 Mar;84(3):743-53. doi: 10.1111/j.1476-5381.1985.tb16157.x. Br J Pharmacol. 1985. PMID: 2580582 Free PMC article.
-
Differential effects of central serotonin manipulation on hyperactive and stereotyped behaviour.Life Sci. 1978 Sep 4;23(9):953-60. doi: 10.1016/0024-3205(78)90222-9. Life Sci. 1978. PMID: 568208 No abstract available.
-
Effects of flunarizine on dopamine dependent behaviours in rats.Indian J Med Sci. 1999 Feb;53(2):43-8. Indian J Med Sci. 1999. PMID: 10798022
Cited by
-
Dopaminergic function in rat brain after oral administration of calcium-channel blockers or haloperidol. A microdialysis study.J Neural Transm Gen Sect. 1994;95(3):195-207. doi: 10.1007/BF01271566. J Neural Transm Gen Sect. 1994. PMID: 7865175
-
Developmental alterations in serotoninergic neurotransmission in Borna disease virus (BDV)-infected rats: a multidisciplinary analysis.J Neurovirol. 2004 Oct;10(5):267-77. doi: 10.1080/13550280490499506. J Neurovirol. 2004. PMID: 15385249
-
Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice.J Neural Transm (Vienna). 1996;103(7):819-31. doi: 10.1007/BF01273360. J Neural Transm (Vienna). 1996. PMID: 8872866
-
Antidepressant-like activity of flunarizine in modified tail suspension test in rats.N Am J Med Sci. 2015 Mar;7(3):100-3. doi: 10.4103/1947-2714.153921. N Am J Med Sci. 2015. PMID: 25839001 Free PMC article.
-
Psychopharmacological properties of calcium channel inhibitors.Psychopharmacology (Berl). 1992;109(1-2):12-29. doi: 10.1007/BF02245476. Psychopharmacology (Berl). 1992. PMID: 1365644 Review.